Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 28, 2020

SELL
$34.44 - $42.23 $576,835 - $707,310
-16,749 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$25.83 - $45.71 $140,360 - $248,388
-5,434 Reduced 24.5%
16,749 $547,000
Q4 2019

Feb 03, 2020

SELL
$37.87 - $45.37 $277,700 - $332,698
-7,333 Reduced 24.84%
22,183 $1 Million
Q3 2019

Oct 23, 2019

SELL
$40.31 - $43.45 $13,463 - $14,512
-334 Reduced 1.12%
29,516 $1.2 Million
Q1 2019

Apr 22, 2019

SELL
$32.91 - $40.75 $164,549 - $203,750
-5,000 Reduced 14.35%
29,850 $1.15 Million
Q4 2018

Feb 11, 2019

SELL
$31.73 - $39.04 $1,586 - $1,952
-50 Reduced 0.14%
34,850 $1.23 Million
Q2 2018

Aug 02, 2018

BUY
$26.84 - $34.32 $936,716 - $1.2 Million
34,900 New
34,900 $1.14 Million
Q4 2017

Jan 26, 2018

SELL
$24.79 - $29.8 $173,530 - $208,600
-7,000 Closed
0 $0
Q3 2017

Oct 31, 2017

BUY
$26.26 - $29.17 $183,820 - $204,190
7,000
7,000 $204,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.